Co.don AG (CNWK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH25684D
- Pages: 26
- October 2018
- Total Views:1147
- Region : Europe
- GlobalData
- Equity Research Report

Details
Summary
Co.don AG (Co.don) offers tissue engineering solutions in cultivation and growth of autologous tissue cells for the regenerative treatment of articular cartilage defects and spinal disc defects. The company manufactures and markets autologous, cell-based pharmaceutical products for biological repair, regeneration and functional maintenance of musculoskeletal system. It also produces autologous cell transplants for the treatment of traumatic, degenerative and circumscribed cartilage defects in vertebrae and joints. Co.don caters its products for orthopaedic and traumatologic surgeons. The company sells its products through a network of distributors in Germany, Greece, Spain, Switzerland and Italy. It has operations in Berlin and Teltow, Germany. Co.don is headquartered in Teltow, Germany.
Co.don AG (CNWK)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Co.don AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Co.don AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Co.don AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Co.don AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Co.don AG, Medical Devices Deals, 2012 to YTD 2018 9
Co.don AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Co.don AG, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
CO.DON to Form Joint Venture with Xintela 11
CO.DON to Enter into Distribution Agreement with Haemo Pharma 12
Xintela to Enter into Agreement with Co.don 13
Equity Offering 14
Co.don Raises USD18.25 Million in Private Placement of Shares 14
Co.don Plans to Raise Funds through Public Offering 15
co.don Finalizes Private Placement Of Shares For USD 5 Million 16
Debt Offering 17
co.don to Raise USD14.4 Million in Private Placement of Bonds Due 2021 17
co.don to Raise USD2.4 Million in Private Placement of Bonds and Warrants Due 2021 18
Co.don AG-Key Competitors 19
Co.don AG-Key Employees 20
Co.don AG-Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Strategy And Business Planning 22
Feb 13, 2018: CO.DON-Strategic growth: establishment of Dutch subsidiary 22
Corporate Communications 23
Dec 18, 2017: CO.DON-Chairman of the Executive Board resigns from his position at the end of 2017 23
Dec 06, 2017: CO.DON- Changes in the Supervisory Board 24
Product News 25
Sep 26, 2017: CO.DON: Largest Product Launch in the Company's History 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26
List Of Figure
List of Figures
Co.don AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Co.don AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Co.don AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Co.don AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Co.don AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Co.don AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Co.don AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Co.don AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Co.don AG, Medical Devices Deals, 2012 to YTD 2018 9
List Of Table
List of Tables
Co.don AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Co.don AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Co.don AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Co.don AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Co.don AG, Deals By Therapy Area, 2012 to YTD 2018 8
Co.don AG, Medical Devices Deals, 2012 to YTD 2018 9
Co.don AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CO.DON to Form Joint Venture with Xintela 11
CO.DON to Enter into Distribution Agreement with Haemo Pharma 12
Xintela to Enter into Agreement with Co.don 13
Co.don Raises USD18.25 Million in Private Placement of Shares 14
Co.don Plans to Raise Funds through Public Offering 15
co.don Finalizes Private Placement Of Shares For USD 5 Million 16
co.don to Raise USD14.4 Million in Private Placement of Bonds Due 2021 17
co.don to Raise USD2.4 Million in Private Placement of Bonds and Warrants Due 2021 18
Co.don AG, Key Competitors 19
Co.don AG, Key Employees 20
Co.don AG, Other Locations 21
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Co.don AG, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
Co.don AG (Co.don) offers tissue engineering solutions in cultivation and growth of autologous tissue cells for the regenerative treatment of articular cartilage defects and spinal disc defects. The company manufactures and markets autologous, cell-based pharmaceutical products for biological repair, regeneration and functional maintenance of musculoskeletal system. It also produces autologous cell transplants for the treatment of traumatic, degenerative and circumscribed cartilage defects in vertebrae and joints. Co.don caters its products for orthopaedic and traumatologic surgeons. The company sells its products through a network of distributors in Germany, Greece, Spain, Switzerland and Italy. It has operations in Berlin and Teltow, Germany. Co.don is headquartered in Teltow, Germany.
Co.don AG (CNWK)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Co.don AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Co.don AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Co.don AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Co.don AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Co.don AG, Medical Devices Deals, 2012 to YTD 2018 9
Co.don AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Co.don AG, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
CO.DON to Form Joint Venture with Xintela 11
CO.DON to Enter into Distribution Agreement with Haemo Pharma 12
Xintela to Enter into Agreement with Co.don 13
Equity Offering 14
Co.don Raises USD18.25 Million in Private Placement of Shares 14
Co.don Plans to Raise Funds through Public Offering 15
co.don Finalizes Private Placement Of Shares For USD 5 Million 16
Debt Offering 17
co.don to Raise USD14.4 Million in Private Placement of Bonds Due 2021 17
co.don to Raise USD2.4 Million in Private Placement of Bonds and Warrants Due 2021 18
Co.don AG-Key Competitors 19
Co.don AG-Key Employees 20
Co.don AG-Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Strategy And Business Planning 22
Feb 13, 2018: CO.DON-Strategic growth: establishment of Dutch subsidiary 22
Corporate Communications 23
Dec 18, 2017: CO.DON-Chairman of the Executive Board resigns from his position at the end of 2017 23
Dec 06, 2017: CO.DON- Changes in the Supervisory Board 24
Product News 25
Sep 26, 2017: CO.DON: Largest Product Launch in the Company's History 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26
List Of Figure
List of Figures
Co.don AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Co.don AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Co.don AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Co.don AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Co.don AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Co.don AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Co.don AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Co.don AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Co.don AG, Medical Devices Deals, 2012 to YTD 2018 9
List Of Table
List of Tables
Co.don AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Co.don AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Co.don AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Co.don AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Co.don AG, Deals By Therapy Area, 2012 to YTD 2018 8
Co.don AG, Medical Devices Deals, 2012 to YTD 2018 9
Co.don AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CO.DON to Form Joint Venture with Xintela 11
CO.DON to Enter into Distribution Agreement with Haemo Pharma 12
Xintela to Enter into Agreement with Co.don 13
Co.don Raises USD18.25 Million in Private Placement of Shares 14
Co.don Plans to Raise Funds through Public Offering 15
co.don Finalizes Private Placement Of Shares For USD 5 Million 16
co.don to Raise USD14.4 Million in Private Placement of Bonds Due 2021 17
co.don to Raise USD2.4 Million in Private Placement of Bonds and Warrants Due 2021 18
Co.don AG, Key Competitors 19
Co.don AG, Key Employees 20
Co.don AG, Other Locations 21
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Co.don AG, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.